aluates Reports

$ 0.0

Automative

Global Monoclonal Antibodies for Alzheimer Disease Market Research Report 2024

Published Date: December 2024

Report Code: QYRE-Auto-33L18661

BUY CHAPTERS

Global Monoclonal Antibodies for Alzheimer Disease Market Research Report 2024

Code: QYRE-Auto-33L18661

Report

December 2024

Pages:70

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Biogen

Eli Lilly & Co

Monoclonal Antibodies for Alzheimer Disease Market Size

The global market for Monoclonal Antibodies for Alzheimer Disease was valued at US$ 10 million in the year 2023 and is projected to reach a revised size of US$ 5423 million by 2030, growing at a CAGR of 67.0% during the forecast period.

Monoclonal Antibodies for Alzheimer Disease Market

Monoclonal Antibodies for Alzheimer Disease (AD) are a class of precision targeted drugs that are specifically used to treat AD. By specifically binding to beta-amyloid (Aβ), they effectively remove toxic Aβ aggregates from the brain to slow cognitive decline and neurodegenerative processes. These antibodies provide therapeutic options for patients with Alzheimer's disease by blocking the pathological cascade through direct action or activation of immune cells to clear Aβ.

North American market for Monoclonal Antibodies for Alzheimer Disease is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Monoclonal Antibodies for Alzheimer Disease is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Monoclonal Antibodies for Alzheimer Disease include Biogen, Eli Lilly & Co., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Monoclonal Antibodies for Alzheimer Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monoclonal Antibodies for Alzheimer Disease.

The Monoclonal Antibodies for Alzheimer Disease market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Monoclonal Antibodies for Alzheimer Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Monoclonal Antibodies for Alzheimer Disease manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Monoclonal Antibodies for Alzheimer Disease Market Report

Report Metric	Details
Report Name	Monoclonal Antibodies for Alzheimer Disease Market
Accounted market size in year	US$ 10 million
Forecasted market size in 2030	US$ 5423 million
CAGR	67.0%
Base Year	year
Forecasted years	2025 - 2030
by Type	350mg/20mL 500mg/5mL
by Application	Hospital Clinic Others
Production by Region	North America Japan
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Biogen, Eli Lilly & Co.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Monoclonal Antibodies for Alzheimer Disease manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Monoclonal Antibodies for Alzheimer Disease in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Monoclonal Antibodies for Alzheimer Disease Market growing?

Ans: The Monoclonal Antibodies for Alzheimer Disease Market witnessing a CAGR of 67.0% during the forecast period 2025-2030.

What is the Monoclonal Antibodies for Alzheimer Disease Market size in 2030?

Ans: The Monoclonal Antibodies for Alzheimer Disease Market size in 2030 will be US$ 5423 million.

Who are the main players in the Monoclonal Antibodies for Alzheimer Disease Market report?

Ans: The main players in the Monoclonal Antibodies for Alzheimer Disease Market are Biogen, Eli Lilly & Co.

What are the Application segmentation covered in the Monoclonal Antibodies for Alzheimer Disease Market report?

Ans: The Applications covered in the Monoclonal Antibodies for Alzheimer Disease Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Monoclonal Antibodies for Alzheimer Disease Market report?

Ans: The Types covered in the Monoclonal Antibodies for Alzheimer Disease Market report are 350mg/20mL, 500mg/5mL

1 Monoclonal Antibodies for Alzheimer Disease Market Overview

1.1 Product Definition

1.2 Monoclonal Antibodies for Alzheimer Disease by Type

1.2.1 Global Monoclonal Antibodies for Alzheimer Disease Market Value Comparison by Type (2024-2030)

1.2.2 350mg/20mL

1.2.3 500mg/5mL

1.3 Monoclonal Antibodies for Alzheimer Disease by Application

1.3.1 Global Monoclonal Antibodies for Alzheimer Disease Market Value by Application (2024-2030)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Monoclonal Antibodies for Alzheimer Disease Market Size Estimates and Forecasts

1.4.1 Global Monoclonal Antibodies for Alzheimer Disease Revenue 2019-2030

1.4.2 Global Monoclonal Antibodies for Alzheimer Disease Sales 2019-2030

1.4.3 Global Monoclonal Antibodies for Alzheimer Disease Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Monoclonal Antibodies for Alzheimer Disease Market Competition by Manufacturers

2.1 Global Monoclonal Antibodies for Alzheimer Disease Sales Market Share by Manufacturers (2019-2024)

2.2 Global Monoclonal Antibodies for Alzheimer Disease Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Monoclonal Antibodies for Alzheimer Disease Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Monoclonal Antibodies for Alzheimer Disease, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Monoclonal Antibodies for Alzheimer Disease, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Monoclonal Antibodies for Alzheimer Disease, Product Type & Application

2.7 Global Key Manufacturers of Monoclonal Antibodies for Alzheimer Disease, Date of Enter into This Industry

2.8 Global Monoclonal Antibodies for Alzheimer Disease Market Competitive Situation and Trends

2.8.1 Global Monoclonal Antibodies for Alzheimer Disease Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Monoclonal Antibodies for Alzheimer Disease Players Market Share by Revenue

2.8.3 Global Monoclonal Antibodies for Alzheimer Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Monoclonal Antibodies for Alzheimer Disease Market Scenario by Region

3.1 Global Monoclonal Antibodies for Alzheimer Disease Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Monoclonal Antibodies for Alzheimer Disease Sales by Region: 2019-2030

3.2.1 Global Monoclonal Antibodies for Alzheimer Disease Sales by Region: 2019-2024

3.2.2 Global Monoclonal Antibodies for Alzheimer Disease Sales by Region: 2025-2030

3.3 Global Monoclonal Antibodies for Alzheimer Disease Revenue by Region: 2019-2030

3.3.1 Global Monoclonal Antibodies for Alzheimer Disease Revenue by Region: 2019-2024

3.3.2 Global Monoclonal Antibodies for Alzheimer Disease Revenue by Region: 2025-2030

3.4 North America Monoclonal Antibodies for Alzheimer Disease Market Facts & Figures by Country

3.4.1 North America Monoclonal Antibodies for Alzheimer Disease Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Monoclonal Antibodies for Alzheimer Disease Sales by Country (2019-2030)

3.4.3 North America Monoclonal Antibodies for Alzheimer Disease Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Monoclonal Antibodies for Alzheimer Disease Market Facts & Figures by Country

3.5.1 Europe Monoclonal Antibodies for Alzheimer Disease Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Monoclonal Antibodies for Alzheimer Disease Sales by Country (2019-2030)

3.5.3 Europe Monoclonal Antibodies for Alzheimer Disease Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Monoclonal Antibodies for Alzheimer Disease Market Facts & Figures by Region

3.6.1 Asia Pacific Monoclonal Antibodies for Alzheimer Disease Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Monoclonal Antibodies for Alzheimer Disease Sales by Region (2019-2030)

3.6.3 Asia Pacific Monoclonal Antibodies for Alzheimer Disease Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Monoclonal Antibodies for Alzheimer Disease Market Facts & Figures by Country

3.7.1 Latin America Monoclonal Antibodies for Alzheimer Disease Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Monoclonal Antibodies for Alzheimer Disease Sales by Country (2019-2030)

3.7.3 Latin America Monoclonal Antibodies for Alzheimer Disease Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Monoclonal Antibodies for Alzheimer Disease Market Facts & Figures by Country

3.8.1 Middle East and Africa Monoclonal Antibodies for Alzheimer Disease Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Monoclonal Antibodies for Alzheimer Disease Sales by Country (2019-2030)

3.8.3 Middle East and Africa Monoclonal Antibodies for Alzheimer Disease Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Monoclonal Antibodies for Alzheimer Disease Sales by Type (2019-2030)

4.1.1 Global Monoclonal Antibodies for Alzheimer Disease Sales by Type (2019-2024)

4.1.2 Global Monoclonal Antibodies for Alzheimer Disease Sales by Type (2025-2030)

4.1.3 Global Monoclonal Antibodies for Alzheimer Disease Sales Market Share by Type (2019-2030)

4.2 Global Monoclonal Antibodies for Alzheimer Disease Revenue by Type (2019-2030)

4.2.1 Global Monoclonal Antibodies for Alzheimer Disease Revenue by Type (2019-2024)

4.2.2 Global Monoclonal Antibodies for Alzheimer Disease Revenue by Type (2025-2030)

4.2.3 Global Monoclonal Antibodies for Alzheimer Disease Revenue Market Share by Type (2019-2030)

4.3 Global Monoclonal Antibodies for Alzheimer Disease Price by Type (2019-2030)

5 Segment by Application

5.1 Global Monoclonal Antibodies for Alzheimer Disease Sales by Application (2019-2030)

5.1.1 Global Monoclonal Antibodies for Alzheimer Disease Sales by Application (2019-2024)

5.1.2 Global Monoclonal Antibodies for Alzheimer Disease Sales by Application (2025-2030)

5.1.3 Global Monoclonal Antibodies for Alzheimer Disease Sales Market Share by Application (2019-2030)

5.2 Global Monoclonal Antibodies for Alzheimer Disease Revenue by Application (2019-2030)

5.2.1 Global Monoclonal Antibodies for Alzheimer Disease Revenue by Application (2019-2024)

5.2.2 Global Monoclonal Antibodies for Alzheimer Disease Revenue by Application (2025-2030)

5.2.3 Global Monoclonal Antibodies for Alzheimer Disease Revenue Market Share by Application (2019-2030)

5.3 Global Monoclonal Antibodies for Alzheimer Disease Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Biogen

6.1.1 Biogen Company Information

6.1.2 Biogen Description and Business Overview

6.1.3 Biogen Monoclonal Antibodies for Alzheimer Disease Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Biogen Monoclonal Antibodies for Alzheimer Disease Product Portfolio

6.1.5 Biogen Recent Developments/Updates

6.2 Eli Lilly & Co.

6.2.1 Eli Lilly & Co. Company Information

6.2.2 Eli Lilly & Co. Description and Business Overview

6.2.3 Eli Lilly & Co. Monoclonal Antibodies for Alzheimer Disease Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Eli Lilly & Co. Monoclonal Antibodies for Alzheimer Disease Product Portfolio

6.2.5 Eli Lilly & Co. Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Monoclonal Antibodies for Alzheimer Disease Industry Chain Analysis

7.2 Monoclonal Antibodies for Alzheimer Disease Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Monoclonal Antibodies for Alzheimer Disease Production Mode & Process

7.4 Monoclonal Antibodies for Alzheimer Disease Sales and Marketing

7.4.1 Monoclonal Antibodies for Alzheimer Disease Sales Channels

7.4.2 Monoclonal Antibodies for Alzheimer Disease Distributors

7.5 Monoclonal Antibodies for Alzheimer Disease Customers

8 Monoclonal Antibodies for Alzheimer Disease Market Dynamics

8.1 Monoclonal Antibodies for Alzheimer Disease Industry Trends

8.2 Monoclonal Antibodies for Alzheimer Disease Market Drivers

8.3 Monoclonal Antibodies for Alzheimer Disease Market Challenges

8.4 Monoclonal Antibodies for Alzheimer Disease Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Biogen

Eli Lilly & Co

List of Tables

Table 1. Global Monoclonal Antibodies for Alzheimer Disease Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Monoclonal Antibodies for Alzheimer Disease Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Monoclonal Antibodies for Alzheimer Disease Market Competitive Situation by Manufacturers in 2023

Table 4. Global Monoclonal Antibodies for Alzheimer Disease Sales (Units) of Key Manufacturers (2019-2024)

Table 5. Global Monoclonal Antibodies for Alzheimer Disease Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Monoclonal Antibodies for Alzheimer Disease Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Monoclonal Antibodies for Alzheimer Disease Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Monoclonal Antibodies for Alzheimer Disease Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Monoclonal Antibodies for Alzheimer Disease, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Monoclonal Antibodies for Alzheimer Disease, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Monoclonal Antibodies for Alzheimer Disease, Product Type & Application

Table 12. Global Key Manufacturers of Monoclonal Antibodies for Alzheimer Disease, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Monoclonal Antibodies for Alzheimer Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibodies for Alzheimer Disease as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Monoclonal Antibodies for Alzheimer Disease Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Monoclonal Antibodies for Alzheimer Disease Sales by Region (2019-2024) & (Units)

Table 18. Global Monoclonal Antibodies for Alzheimer Disease Sales Market Share by Region (2019-2024)

Table 19. Global Monoclonal Antibodies for Alzheimer Disease Sales by Region (2025-2030) & (Units)

Table 20. Global Monoclonal Antibodies for Alzheimer Disease Sales Market Share by Region (2025-2030)

Table 21. Global Monoclonal Antibodies for Alzheimer Disease Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Monoclonal Antibodies for Alzheimer Disease Revenue Market Share by Region (2019-2024)

Table 23. Global Monoclonal Antibodies for Alzheimer Disease Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Monoclonal Antibodies for Alzheimer Disease Revenue Market Share by Region (2025-2030)

Table 25. North America Monoclonal Antibodies for Alzheimer Disease Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Monoclonal Antibodies for Alzheimer Disease Sales by Country (2019-2024) & (Units)

Table 27. North America Monoclonal Antibodies for Alzheimer Disease Sales by Country (2025-2030) & (Units)

Table 28. North America Monoclonal Antibodies for Alzheimer Disease Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Monoclonal Antibodies for Alzheimer Disease Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Monoclonal Antibodies for Alzheimer Disease Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Monoclonal Antibodies for Alzheimer Disease Sales by Country (2019-2024) & (Units)

Table 32. Europe Monoclonal Antibodies for Alzheimer Disease Sales by Country (2025-2030) & (Units)

Table 33. Europe Monoclonal Antibodies for Alzheimer Disease Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Monoclonal Antibodies for Alzheimer Disease Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Monoclonal Antibodies for Alzheimer Disease Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Monoclonal Antibodies for Alzheimer Disease Sales by Region (2019-2024) & (Units)

Table 37. Asia Pacific Monoclonal Antibodies for Alzheimer Disease Sales by Region (2025-2030) & (Units)

Table 38. Asia Pacific Monoclonal Antibodies for Alzheimer Disease Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Monoclonal Antibodies for Alzheimer Disease Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Monoclonal Antibodies for Alzheimer Disease Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Monoclonal Antibodies for Alzheimer Disease Sales by Country (2019-2024) & (Units)

Table 42. Latin America Monoclonal Antibodies for Alzheimer Disease Sales by Country (2025-2030) & (Units)

Table 43. Latin America Monoclonal Antibodies for Alzheimer Disease Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Monoclonal Antibodies for Alzheimer Disease Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Monoclonal Antibodies for Alzheimer Disease Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Monoclonal Antibodies for Alzheimer Disease Sales by Country (2019-2024) & (Units)

Table 47. Middle East and Africa Monoclonal Antibodies for Alzheimer Disease Sales by Country (2025-2030) & (Units)

Table 48. Middle East and Africa Monoclonal Antibodies for Alzheimer Disease Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Monoclonal Antibodies for Alzheimer Disease Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Monoclonal Antibodies for Alzheimer Disease Sales (Units) by Type (2019-2024)

Table 51. Global Monoclonal Antibodies for Alzheimer Disease Sales (Units) by Type (2025-2030)

Table 52. Global Monoclonal Antibodies for Alzheimer Disease Sales Market Share by Type (2019-2024)

Table 53. Global Monoclonal Antibodies for Alzheimer Disease Sales Market Share by Type (2025-2030)

Table 54. Global Monoclonal Antibodies for Alzheimer Disease Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Monoclonal Antibodies for Alzheimer Disease Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Monoclonal Antibodies for Alzheimer Disease Revenue Market Share by Type (2019-2024)

Table 57. Global Monoclonal Antibodies for Alzheimer Disease Revenue Market Share by Type (2025-2030)

Table 58. Global Monoclonal Antibodies for Alzheimer Disease Price (US$/Unit) by Type (2019-2024)

Table 59. Global Monoclonal Antibodies for Alzheimer Disease Price (US$/Unit) by Type (2025-2030)

Table 60. Global Monoclonal Antibodies for Alzheimer Disease Sales (Units) by Application (2019-2024)

Table 61. Global Monoclonal Antibodies for Alzheimer Disease Sales (Units) by Application (2025-2030)

Table 62. Global Monoclonal Antibodies for Alzheimer Disease Sales Market Share by Application (2019-2024)

Table 63. Global Monoclonal Antibodies for Alzheimer Disease Sales Market Share by Application (2025-2030)

Table 64. Global Monoclonal Antibodies for Alzheimer Disease Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Monoclonal Antibodies for Alzheimer Disease Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Monoclonal Antibodies for Alzheimer Disease Revenue Market Share by Application (2019-2024)

Table 67. Global Monoclonal Antibodies for Alzheimer Disease Revenue Market Share by Application (2025-2030)

Table 68. Global Monoclonal Antibodies for Alzheimer Disease Price (US$/Unit) by Application (2019-2024)

Table 69. Global Monoclonal Antibodies for Alzheimer Disease Price (US$/Unit) by Application (2025-2030)

Table 70. Biogen Company Information

Table 71. Biogen Description and Business Overview

Table 72. Biogen Monoclonal Antibodies for Alzheimer Disease Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Biogen Monoclonal Antibodies for Alzheimer Disease Product

Table 74. Biogen Recent Developments/Updates

Table 75. Eli Lilly & Co. Company Information

Table 76. Eli Lilly & Co. Description and Business Overview

Table 77. Eli Lilly & Co. Monoclonal Antibodies for Alzheimer Disease Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Eli Lilly & Co. Monoclonal Antibodies for Alzheimer Disease Product

Table 79. Eli Lilly & Co. Recent Developments/Updates

Table 80. Key Raw Materials Lists

Table 81. Raw Materials Key Suppliers Lists

Table 82. Monoclonal Antibodies for Alzheimer Disease Distributors List

Table 83. Monoclonal Antibodies for Alzheimer Disease Customers List

Table 84. Monoclonal Antibodies for Alzheimer Disease Market Trends

Table 85. Monoclonal Antibodies for Alzheimer Disease Market Drivers

Table 86. Monoclonal Antibodies for Alzheimer Disease Market Challenges

Table 87. Monoclonal Antibodies for Alzheimer Disease Market Restraints

Table 88. Research Programs/Design for This Report

Table 89. Key Data Information from Secondary Sources

Table 90. Key Data Information from Primary Sources

Table 91. Authors List of This Report

List of Figures

Figure 1. Product Picture of Monoclonal Antibodies for Alzheimer Disease

Figure 2. Global Monoclonal Antibodies for Alzheimer Disease Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Monoclonal Antibodies for Alzheimer Disease Market Share by Type: 2023 & 2030

Figure 4. 350mg/20mL Product Picture

Figure 5. 500mg/5mL Product Picture

Figure 6. Global Monoclonal Antibodies for Alzheimer Disease Market Value by Application (2024-2030) & (US$ Million)

Figure 7. Global Monoclonal Antibodies for Alzheimer Disease Market Share by Application: 2023 & 2030

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Others

Figure 11. Global Monoclonal Antibodies for Alzheimer Disease Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Monoclonal Antibodies for Alzheimer Disease Market Size (2019-2030) & (US$ Million)

Figure 13. Global Monoclonal Antibodies for Alzheimer Disease Sales (2019-2030) & (Units)

Figure 14. Global Monoclonal Antibodies for Alzheimer Disease Average Price (US$/Unit) & (2019-2030)

Figure 15. Monoclonal Antibodies for Alzheimer Disease Report Years Considered

Figure 16. Monoclonal Antibodies for Alzheimer Disease Sales Share by Manufacturers in 2023

Figure 17. Global Monoclonal Antibodies for Alzheimer Disease Revenue Share by Manufacturers in 2023

Figure 18. Global 5 and 10 Largest Monoclonal Antibodies for Alzheimer Disease Players: Market Share by Revenue in Monoclonal Antibodies for Alzheimer Disease in 2023

Figure 19. Monoclonal Antibodies for Alzheimer Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 20. Global Monoclonal Antibodies for Alzheimer Disease Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Monoclonal Antibodies for Alzheimer Disease Sales Market Share by Country (2019-2030)

Figure 22. North America Monoclonal Antibodies for Alzheimer Disease Revenue Market Share by Country (2019-2030)

Figure 23. United States Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Monoclonal Antibodies for Alzheimer Disease Sales Market Share by Country (2019-2030)

Figure 26. Europe Monoclonal Antibodies for Alzheimer Disease Revenue Market Share by Country (2019-2030)

Figure 27. Germany Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Monoclonal Antibodies for Alzheimer Disease Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Monoclonal Antibodies for Alzheimer Disease Revenue Market Share by Region (2019-2030)

Figure 34. China Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. China Taiwan Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Southeast Asia Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Latin America Monoclonal Antibodies for Alzheimer Disease Sales Market Share by Country (2019-2030)

Figure 42. Mexico Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Brazil Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Argentina Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Colombia Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Middle East and Africa Monoclonal Antibodies for Alzheimer Disease Sales Market Share by Country (2019-2030)

Figure 47. Middle East and Africa Monoclonal Antibodies for Alzheimer Disease Revenue Market Share by Country (2019-2030)

Figure 48. Turkey Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. UAE Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Global Sales Market Share of Monoclonal Antibodies for Alzheimer Disease by Type (2019-2030)

Figure 52. Global Revenue Market Share of Monoclonal Antibodies for Alzheimer Disease by Type (2019-2030)

Figure 53. Global Monoclonal Antibodies for Alzheimer Disease Price (US$/Unit) by Type (2019-2030)

Figure 54. Global Sales Market Share of Monoclonal Antibodies for Alzheimer Disease by Application (2019-2030)

Figure 55. Global Revenue Market Share of Monoclonal Antibodies for Alzheimer Disease by Application (2019-2030)

Figure 56. Global Monoclonal Antibodies for Alzheimer Disease Price (US$/Unit) by Application (2019-2030)

Figure 57. Monoclonal Antibodies for Alzheimer Disease Value Chain

Figure 58. Monoclonal Antibodies for Alzheimer Disease Production Process

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions